Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip

Capricor Therapeutics Inc. (NASDAQ: CAPR) Listen to this Section


$3.89
-0.0100 ( -0.26% ) 139.5K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Market Data


Open


$3.89

Previous close


$3.90

Volume


139.5K

Market cap


$126.58M

Day range


$3.85 - $4.08

52 week range


$2.68 - $8.22

Insider Ownership Transactions

Total Amount Purchased: -373,435.00 | $ -1,452,662.15

Date Type Amount Purchased Purchaser
2024-01-04 Sale -29250.00 COLLIER EARL M JR
2024-01-04 Sale -200000.00 Litvack Frank
2024-01-04 Sale -80000.00 Krasney Karen
2024-01-04 Sale -85000.00 Bergmann Anthony
2023-10-24 Sale -2178.00 Bergmann Anthony
2023-10-13 Buy 410.00 Musket David B
2023-10-12 Buy 10000.00 COLLIER EARL M JR
2023-10-11 Buy 5083.00 Musket David B
2023-10-10 Buy 5000.00 Auwaerter Paul Gisbert
2023-10-06 Buy 2500.00 Musket David B

SEC Fillings


Form Type Description Pages Date
ars Annual reports 1 Apr 01, 2024
def Proxies and info statements 19 Apr 01, 2024
pre Proxies and info statements 18 Mar 20, 2024
10-k Annual reports 65 Mar 11, 2024
8-k 8K-related 16 Feb 29, 2024
8-k 8K-related 12 Jan 11, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.